Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

In the Triangle, office vacancies are at record highs. Some buildings, like Roxboro at Venable Center in Durham, are sitting ...

Office-to-residential conversions are climbing to new heights in the new year. According to a recent RentCafe report, a ...

A new tower is rising in Fort Greene, and it might just win over audiophiles. In October 2023, developer Charney Companies ...

CetraRuddy, a New York office, was behind the largest office-to-residential conversion project in New York City to date. 25 ...

In the face of employee backlash over JPMorgan Chase’s 5-day-a-week return to work mandate, company leaders are hoping their ...

Integrated architecture and design firm Lamar Johnson Collaborative completed the new North American headquarters for global ...

A new report from Gensler and the Pew Charitable Trust proposes converting old office buildings into SRO-style housing.